Michael W. on Global Addiction Treatment and the Abstinence Model — Part 1 — Mike

About This Speaker Tape

Mike, a medical director and recovering alcoholic and addict, presents a detailed overview of global trends in addiction treatment based on his experience attending the International Society of Addiction Medicine (ISAM) conference in Japan. He explores how different cultures approach substance use disorders, contrasting the medical models of Western nations with the risk-reduction strategies used in other parts of the world.

The presentation covers a wide geographical range, discussing the use of naltrexone implants in Australia, the high rates of sedative-hypnotic abuse in Japan, and the controversial heroin clinics in Switzerland. Mike highlights a recurring global tension between the goal of total abstinence and the practice of harm reduction, noting that many countries prioritize keeping patients alive through medication-assisted treatment over complete sobriety.

Throughout the talk, Mike identifies commonalities across borders, such as the rising threat of prescription drug abuse and the intersection of addiction with infectious diseases like HIV. He concludes by reflecting on the varying ethical stances on medications like Antabuse and the necessity of specialized addiction medicine training to improve patient outcomes worldwide.

Topics

Timestamps

• 0:00 Introduction of Mike, a medical director and recovering alcoholic and addict.
• 3:34 Discussion on naltrexone implants and overdose prevention in Australia.
• 8:20 Analysis of HIV testing and linkage to care within Chinese methadone clinics.
• 12:34 Debate over the efficacy and ethics of Disulfiram (Antabuse) in England.
• 18:55 Contrasting abstinence goals with risk reduction and controlled drinking in Germany.
• 25:40 Overview of sedative-hypnotic abuse and suicide rates in Japan.
• 34:15 Discussion of the high-purity street heroin (kerak) and fertility in Iran.
• 41:20 Examination of the Swiss harm reduction model and legal heroin clinics.